RenovoRx, Inc. — Director's Dealing 2021

Aug 25, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RenovoRx, Inc. (RNXT)
CIK: 0001574094
Period of Report: 2021-08-25

Reporting Person: RYAN UNA S (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.65	2029-06-13	Common Stock (16000)		Direct

Footnotes

F1: 1/48th of the shares subject to the option began vesting monthly on September 12, 2018, and the remaining unvested shares will continue to vest according to the same schedule until fully vested on September 12, 2022.